Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2728 of 5804
-
Can a Parent-Training program curb childhood obesity?
Prevention CompletedParents are children's primary role models, are food and physical activity gatekeepers, and create the structure/lifestyle environment within the home. Thus, parents strongly influence children's weight-related behaviors and have the opportunity to cultivate a "culture of health"…
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated Jun 27, 2026 12:31 UTC
-
Could CO2 be the key to healing stubborn diabetic wounds?
Disease control CompletedThe research is designed to evaluate influence of transcutaneous application of CO2 (carbon dioxide) on chronic wound healing. Transcutaneous application of CO2 is known to have immediate effect on vasodilatation and elevates oxygen release from Hb via the Bohr effect. After repe…
Phase: NA • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New study tests online classes to stop baby weight gain in military homes
Prevention Recruiting nowThe goal of this clinical trial is to test whether an adaptation of an evidence-based, couple-based preventive intervention at the transition to parenthood improves reduces obesity risk among infants and parents in military families via improved interparental support and coordina…
Phase: NA • Sponsor: Penn State University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC
-
Could chemicals in our environment be causing earlier puberty in girls?
Knowledge-focused Recruiting nowVarious studies show an increase in the number of cases of early puberty in girls with breast development with a variable clinical presentation and evolution. This increasing phenomenon concerns girls between 6 and 8 years old. In a large number of cases, from 70 to 95% depending…
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Brain zaps may supercharge emotion control therapy
Knowledge-focused Recruiting nowThe primary goal of this clinical trial is to evaluate the unique neural and behavioral effects of a one-session training combining emotion regulation skills training, with excitatory repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlP…
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Village health workers take on diabetes with app support
Disease control OngoingThis cluster-randomized intervention is embedded in the ComBaCaL (Community-Based Chronic disease care Lesotho) cohort study (EKNZ ID AO\_2022-00058, clinicaltrials.gov ID NCT05596773, Lesotho NH-REC ID 210-2022), a platform for the investigation of chronic diseases and their man…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Tear test could spot eye disease risk in thyroid patients
Knowledge-focused OngoingThe aim of this research project is to develop a non-invasive, simple, robust, and sensitive prognostic test that can identify hyperthyroidism patients who are at risk of developing Graves' Orbitopathy. This phase of the study is a research phase in which we analyze blood samples…
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Proton 'GRID' radiation aims to safely shrink large tumors and ease pain
Symptom relief OngoingSpatially fractionated radiotherapy (SFRT or GRID) addresses some limitations of traditional stereotactic body radiation therapy by relying on beam collimation to create high-dose "peaks" and intervening low-dose "valleys" throughout the target volume. Standard palliative radioth…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Exercise plus hormone therapy may cut heart risk in menopause
Disease control Recruiting nowThis trial investigates whether supervised training in combination with hormonal substitution therapy has an impact on body composition, cardiovascular risk, risk for dementia, osteoporosis and insulin sensitivity in postmenopausal women.
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New approach aims to boost HIV prevention in LGBTQ+ individuals struggling with addiction
Prevention TerminatedASK-PrEP is a two-arm randomized controlled trial (RCT), with a Stepped Care approach, among HIV-negative trans women and men who have sex with men with a substance use disorder (SUD). Participants will be randomized (3:1) to the ASK-PrEP Stepped Care arm or Standard of Care (SOC…
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
New drug XTX301 takes on advanced cancers in first human trial
Disease control Recruiting nowThis is a first-in-human, multicenter, Phase 1/2, open-label study designed to evaluate the safety and tolerability of XTX301 as monotherapy in patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Xilio Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Scientists hunt for relapse clues in TTP Patients' immune cells
Knowledge-focused Recruiting nowThe general objective of the proposed project is to characterise phenotypically and functionally ADAMTS13-specific memory B lymphocytes and autoreactive T lymphocytes, in particular follicular helper T lymphocytes, in the acute phase of the disease, but also during its progressio…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can a magnetic pulse to the cerebellum calm Parkinson's symptoms?
Symptom relief CompletedThe goal of this clinical trial is to learn about the efficacy of low-frequency rTMS of the cerebellum in Parkinson's disease.
Phase: NA • Sponsor: Jiangsu Province Nanjing Brain Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Virtual worlds could help men with HIV fight heart disease
Disease control CompletedThe investigator is testing a virtual environment (VE) to address prevention of HIV-related comorbidities.
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Heart stent SUPRAFLEX CRUZ under Post-Market scrutiny for multivessel disease
Disease control Recruiting nowMulticenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Medical Device Regulations (MDR) with multivessel coronary disease requirements in all the CONSECUTIVE patients treated with (SUPRAF…
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study probes why brain tumors resist treatment
Knowledge-focused OngoingThe purpose of this study to see how the brain absorbs, distributes, and gets rid of tucatinib in people who have HER2+ cancers (breast cancer, NSCLC, CRC, or GEC) that have spread to the brain, and to learn more about how cancer cells develop resistance to treatment. The researc…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Better scans during spine radiation may boost quality of life
Symptom relief Recruiting nowTo learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is r…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New antibody drug YK012 takes aim at Hard-to-Treat lymphoma
Disease control Recruiting nowThis study aims to provide a basis for further clinical development of YK012.
Phase: PHASE1 • Sponsor: Excyte Biopharma Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Valbenazine shows promise for easing involuntary movements in tardive dyskinesia
Symptom relief CompletedThis study will evaluate the effectiveness of valbenazine on patient- and clinician-reported outcomes assessing health-related quality of life, functioning, and treatment effect in participants with tardive dyskinesia (TD) who are receiving valbenazine for up to 24 weeks.
Phase: PHASE4 • Sponsor: Neurocrine Biosciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New drug duo aims to boost immune attack on tough cancers
Disease control OngoingThe purpose of this study is to test the safety and tolerability of HFB200603 as a single agent and in combination with tislelizumab in patients with advanced cancers. There are two parts in this study. During the escalation part, groups of participants will receive increasing do…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC